Impact of Tadalafil (LY450190) Once a Day or Tadalafil on Demand Compared to Sildenafil Citrate on Demand on Treatment Discontinuation in Patients With Erectile Dysfunction Who Are naive to PDE5 Inhibitors.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2014
At a glance
- Drugs Sildenafil (Primary) ; Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 21 Nov 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004040).
- 18 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 18 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.